. . . . . "S&T TWOC Project - version 4" . "S&T TWOC version 3" . "2"^^ . "2023-07-20T09:47:20.558079"^^ . . . "for COVID-19 therapy" . "(424, 434)" . "considered" . "498" . "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone" . "(424, 434)" . "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." . "8j41d0a3" . "8j41d0a3-TRIPLE-ABSTRACT-2" . "nafamostat" . "covid-19" . "RSA" . "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" . "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" . . .